Ken Griffin PROGENICS PHARMACEUTICALS IN Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
N/A
-43,193 Closed
0 $0
Q1 2020

May 15, 2020
BUY
N/A
25,995 Added 151.15%
43,193 $164,000
Q3 2019

Nov 14, 2019
BUY
N/A
1,042 Added 6.45%
17,198 $0
Q2 2019

Aug 14, 2019
SELL
N/A
-458,146 Reduced 96.59%
16,156 $100,000
Q1 2019

May 15, 2019
SELL
N/A
-1,104,258 Reduced 69.95%
474,302 $0
Q4 2018

Feb 14, 2019
SELL
N/A
-60,424 Reduced 3.69%
1,578,560 $0
Q3 2018

Nov 13, 2018
BUY
N/A
1,502,039 Added 1096.82%
1,638,984 $0
Q2 2018

Aug 10, 2018
BUY
N/A
32,256 Added 30.81%
136,945 $0
Q1 2018

May 11, 2018
BUY
N/A
34,242 Added 48.61%
104,689 $781,000
Q4 2017

Feb 09, 2018
BUY
N/A
47,130 Added 202.13%
70,447 $419,000
Q3 2017

Nov 09, 2017
BUY
N/A
23,317
23,317 $172,000
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email